bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Down 10.2% in January

bioMérieux S.A. (OTCMKTS:BMXMF) was the recipient of a large decline in short interest in January. As of January 31st, there was short interest totalling 104,300 shares, a decline of 10.2% from the January 15th total of 116,100 shares. Based on an average trading volume of 4,900 shares, the days-to-cover ratio is currently 21.3 days.

bioMérieux Trading Down 3.1 %

OTCMKTS:BMXMF opened at $116.75 on Tuesday. bioMérieux has a twelve month low of $93.50 and a twelve month high of $123.44. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.21 and a quick ratio of 1.20. The company’s 50 day moving average is $111.60 and its two-hundred day moving average is $111.44.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.